As IGFBP5 impairs the binding of IGF1 to the cell-surface receptor IGF1R [20], its increased expression in activated HSC and myofibroblasts may reduce IGF1 signalling and, thus, promote liver fibrosis. The gene discussed is IGF1; the disease is Hepatic fibrosis.